Publicaciones (15) Publicaciones de LUCÍA INCHAUSTI LÓPEZ DE LARRUCEA

2023

  1. Psychosis and substance abuse increase the COVID-19 mortality risk

    Psychological Medicine, Vol. 53, Núm. 9, pp. 4236-4244

  2. The transition to Schizophrenia spectrum disorder from a first psychotic episode that did or did not appear to be induced by substance use

    Psychiatry Research, Vol. 328

2022

  1. Diagnostic stability in substance-induced psychosis

    Revista de Psiquiatria y Salud Mental, Vol. 15, Núm. 4, pp. 272-280

2018

  1. The relationship between theory of mind deficits and neurocognition in first episode-psychosis

    Psychiatry Research, Vol. 268, pp. 361-367

2015

  1. Undertreatment of human immunodeficiency virus in psychiatric inpatients: A cross-sectional study of seroprevalence and associated factors

    Neuropsychiatric Disease and Treatment, Vol. 11, pp. 1421-1426

2011

  1. Variability of plasma homovanillic acid over 13 months in patients with Schizophrenia; Relationship with the clinical response and the wisconsin card sort test

    Neurochemical Research, Vol. 36, Núm. 8, pp. 1336-1343

2010

  1. Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients

    Neurochemistry International, Vol. 56, Núm. 6-7, pp. 774-779

  2. Depersonalization in patients with schizophrenia spectrum disorders, first-degree relatives and normal controls

    Psychopathology, Vol. 43, Núm. 3, pp. 141-149

  3. Lifetime Sexual Behavior of Psychiatric Inpatients

    Journal of Sexual Medicine, Vol. 7, Núm. 9, pp. 3045-3056

2009

  1. Agonistas y antagonistas del receptor de benzodiazepinas: Oxibato sódico

    Tratado de psicofarmacología: bases y aplicación clínica (Médica Panamericana), pp. 401-404

  2. Antagonistas de la dopamina-serotonina. Antipsicóticos atípicos de segunda generación: Melperona

    Tratado de psicofarmacología: bases y aplicación clínica (Médica Panamericana), pp. 481-483

  3. Antiepilépticos: Topiramato

    Tratado de psicofarmacología: bases y aplicación clínica (Médica Panamericana), pp. 358-362

  4. Inhibidores de la acetilcolinesterasa: Rivastigmina

    Tratado de psicofarmacología: bases y aplicación clínica (Médica Panamericana), pp. 274-278

  5. Inhibidores de la recaptación de serotonina-noradrenalina: Duloxetina

    Tratado de psicofarmacología: bases y aplicación clínica (Médica Panamericana), pp. 623-628

  6. Temperament and character dimensions in patients with schizophrenia, relatives, and controls.

    The Journal of nervous and mental disease, Vol. 197, Núm. 7, pp. 514-519